newsfilter
← Latest News
PR Newswire·

NeuroSense Provides Business Update and Third Quarter 2024 Financial Results

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe...